Health

BioNTech produces 10 times more antibodies than China’s Sinovac: HK study

  HONG KONG, China (AFP) -- People who received BioNTech's coronavirus vaccine had ten times the amount of antibodies than…

90-year-old infected with ‘two virus variants at once’

PARIS, France (AFP) -- A 90-year-old woman who died after falling ill with Covid-19 was infected with both the Alpha…

Sinovac’s CoronaVac jab less effective against Gamma variant: study

  PARIS, France (AFP) -- The Chinese CoronaVac jab, a key tool in Brazil's fight against Covid-19, is less effective…

Pfizer-BioNTech to seek authorization for 3rd Covid shot in US: statement

WASHINGTON, United States (AFP) -- Pfizer and BioNTech announced Thursday they would seek regulatory authorization for a third dose of…

WHO urges ‘extreme caution’ in lifting Covid restrictions

by Robin MILLARD GENEVA, Switzerland (AFP) -- The World Health Organization on Wednesday urged "extreme caution" for countries considering lifting…

New Lambda “variant of interest” causing concern as Chilean researchers note its higher infectivity, immune escape

Lambda variant has now been detected in at least 29 countries including South America, US, Australia, Israel and parts of…

J&J’s says its Covid-19 vaccine effectively combats Delta variant

Washington, United States -- ( AFP)Johnson and Johnson's single-shot Covid-19 vaccine is effective against the highly contagious Delta variant, with…

WHO warns against vaccine favoritism; says all COVID jabs it approved for EUL are “safe and effective”

WHO issues "Joint COVAX Statement on the Equal Recognition of Vaccines" amid some countries' preference for Western-made jabs    …

Double Covid jab seems to curb Delta variant: EMA

  THE HAGUE, Netherlands (AFP) -- Two doses of Covid vaccine appear to provide protection against the rapidly spreading Delta…

France’s Sanofi to invest 2 billion euros in mRNA vaccines

  by Marie-Morgane LE MOEL Agence France Presse PARIS, France (AFP) -- French pharmaceutical giant Sanofi said Tuesday that it…

This website uses cookies.